Point of Care Glucose Testing Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The Point of Care Glucose Testing Market size is expected to grow at an annual average of 10% during 2021-2027. Point-of-care examinations (POCTs) are also known as close-patient examinations used to monitor people with diabetes. Point-of-care blood glucose testing is a valuable tool used to manage diabetic patients in an outpatient setting. Additionally, point-of-care blood glucose testing devices and electronic medical records allow immediate sharing of test results with health care providers.

The following segmentation are covered in this report:

By Platform

• Lateral Flow Assays
• Immunoassays
• Microfluidics 1
• Molecular Diagnostics
• Dipsticks

 By End-use

• Outpatient & Ambulatory Care Facilities
• Hospitals & Critical Care Centers
• Home Care Settings 5
• Other End Users

 Company Profile

• Roche Diabetes Care
• LifeScan IP Holdings, LLC.
• Abbott
• Ascensia Diabetes Care
• Trividia Health
• Nova Biomedical

Scope of the report

The research study analyses the Point of Care Glucose Testing Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Point of Care Glucose Testing Market Report

• What was the Point of Care Glucose Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Point of Care Glucose Testing Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.